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Previous eﬀorts to improve the eﬃciency of cellular reprogramming for the generation of induced pluripotent stem cells (iPSCs)
have focused mainly on transcription factors and small molecule combinations. Here, we report the results of our focus instead on
thephenotypeofthecellstargetedforreprogramming.Weﬁndthatadultmousepancreatictissuestemcellsderivedbythemethod
ofsuppressionofasymmetriccellkinetics(SACK)acquireincreasedpotencysimplybycultureunderconditionsfortheproduction
andmaintenanceofpluripotentstemcells.Moreover,supplementationwiththeSACKagentxanthine,whichpromotessymmetric
self-renewal, signiﬁcantly increases the eﬃciency and degree of acquisition of pluripotency properties. In transplantation analyses,
clonalreprogrammedpancreaticstemcellsproduceslow-growingtumorswithtissuederivativeofallthreeembryonicgermlayers.
This acquisition of pluripotency, without transduction with exogenous transcription factors, supports the concept that tissue stem
cells are predisposed to cellular reprogramming, particularly when symmetrically self-renewing.
1.Introduction
Direct reprogramming of somatic cells into pluripotent stem
cells (termed induced pluripotent stem cells (iPSCs)) has
been achieved by inducing the expression of transcription
factors associated with pluripotent cell states and cell trans-
formation [1]. The ﬁrst successful attempt used over-expres-
sion of four transcription factors, Oct4, Sox2, Klf4, and c-
Myc, to convert somatic ﬁbroblasts to iPSCs [2–4]. In subse-
quent studies, iPSCs were generated by overexpressing only
the ﬁrst three of these factors, and combinations using other
transcription factors (e.g., Nanog, Lin28, Nr5a2, Esrrb) were
also successful [5–8].
Progress in iPSC technology development has faced two
main problems: (1) risk of cell transformation and mutation
by transduced gene expression constructs and (2) poor eﬃ-
ciency. Transduction of somatic cells with synthetic mRNAs
or proteins has addressed the gene transfer problem [9–11].
Other strategies have been the use of one or two of the
transcription factors in combination with small molecules
to achieve reprogramming [12–14]. On the other hand,
the low eﬃciency of reprogramming continues to present
a major challenge, especially with gene-free strategies. With
the stochastic model for reprogramming now generally ac-
cepted [15], one approach to increasing reprogramming
eﬃciency might be the use of cell populations whose active
genetic networks inherently share similarities with those of
pluripotent stem cells. Unipotent and multipotent tissue-
speciﬁc stem cells may have this character.
Previous iPSC studies have focused mainly on tran-
scription factor combinations necessary for the induction
and maintenance of a pluripotent state. To the authors’
knowledge, the possibility of tissue stem cells being involved
as a predisposed population, though considered, previously
has not been investigated speciﬁcally. In the closest example
on the topic, cultures enriched for neural stem cells were
shown to be more eﬃciently reprogrammed than routinely
used ﬁbroblast populations [16–18]. However, this property
was attributed to the expression of complementing factors in
these cells, instead of their tissue stem cell phenotype per se.
Other speciﬁc investigations of the role of tissue stem cells2 Journal of Biomedicine and Biotechnology
may have been discouraged by the well-known diﬃculty of
obtaining quantities of these cells suﬃcient for informative
experimental analyses [19].
Here,wereporttheinvestigationofreadilyavailableadult
mouse pancreatic stem cell strains for predisposition for
pluripotency reprogramming. These clonal tissue stem cells
were expanded by the method of suppression of asymmetric
cell kinetics (SACK). The SACK method is based on the
concept that tissue stem cells are diﬃcult to expand ex vivo
because of their inherent asymmetric self-renewal kinetics
[19, 20]. In vivo, asymmetric self-renewal allows tissue stem
cells to maintain their own number while continuously
replenishing diﬀerentiated tissue cells. However, in vitro, the
same process leads to the dilution and loss of tissue stem
cells among their accumulating lineage-committed progeny
cells.TheSACKmethodusesspeciﬁcguanineribonucleotide
precursors to shift tissue stem cells reversibly from asymmet-
ric self-renewal kinetics to symmetric self-renewal kinetics,
which promotes their exponential expansion in culture
[21]. We found that, when simply transferred to culture
conditions used for pluripotent stem cells, SACK-expanded
pancreatic stem cells acquired properties of pluripotent
stem cells. Moreover, inclusion of xanthine (Xn), the SACK
agent used for their derivation, signiﬁcantly increased their
acquisition of properties characteristic of pluripotency.
These ﬁndings suggest that targeting symmetrically self-
renewing tissue stem cells could signiﬁcantly increase the
eﬃciency of pluripotency reprogramming when combined
with other reprogramming strategies.
2.MaterialsandMethods
2.1. Cell Culture. Mouse pancreatic cell strain (mPanstra)
cells; (see Section 3 for detailed description) were main-
tained in high-glucose Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% dialyzed fetal bovine
serum (DFBS; GIBCO, Invitrogen, Carlsbad, Calif, USA),
100U/mL penicillin, 100μg/mL streptomycin, and 1mM
xanthine (Xn, Sigma Chemical Co., St. Louis, Mo, USA),
at 37◦C in a humidiﬁed incubator with 5% CO2.S T O
ﬁbroblasts (American Type Culture Collection, Manassas,
Va, USA) were maintained in the same media, except the
DFBS which was replaced with fetal bovine serum (FBS;
Sigma Chemical Co.), and no Xn was added. Mouse
embryonic stem cells (mESCs) [22]w e r ec u l t u r e d ,o nS T O
feeder layers inactivated with mitomycin C (Roche Applied
Science, Indianapolis, Ind, USA), in high-glucose DMEM
supplemented with 20% heat-inactivated FBS (Sigma),
100U/mL penicillin, 100μg/mL streptomycin, 2mM L-glu-
tamine, nonessential amino acids (GIBCO), 50μM β-mer-
captoethanol, and 10ng/mL leukemia inhibitory factor. Re-
programmed cells were cultured on mitotically inactivated
STO feeder layers. The media were either the mPanstra
maintenance medium, mESCs medium, or another mESCs
medium in which the heat-inactivated serum was replaced
with 15% KnockOut Serum Replacement (GIBCO). For
each of these reprogramming conditions, one series was
maintained without Xn and another with 1mM Xn. For the
initiation of reprogramming, cells were plated at a density
of 1.5 × 105 cells per 10cm diameter dish. Three plates were
used for each condition. Two weeks later, cells from one plate
were frozen, another plate was used for alkaline phosphatase
staining, and isolated colonies were clonally expanded from
the remaining plate.
2.2. Indirect In Situ Immunoﬂuorescence (ISIF) Analyses.
C e l l sw e r eﬁ x e df o r2 0m i n u t e sa tr o o mt e m p e r a t u r ew i t h
4% formaldehyde in phosphate-buﬀered saline (PBS). They
were permeabilized by incubating them with 2% bovine
serum albumin (BSA), 0.2% dried milk, and 0.4% Triton
X-100 in PBS for 10 minutes at room temperature. Cells
were blocked for one hour at 4◦C with a 3% dilution
in PBS of the serum from the source-animal species of
the secondary antibody. The rabbit polyclonal anti-Oct4
and mouse monoclonal anti-Klf4 antibodies (Stemgent,
Cambridge, Mass, USA) were diluted at 1:200 in blocking
solution and incubated overnight with the cells at 4◦C. Incu-
bation with 1:200 dilutions of secondary antibodies (goat
polyclonal anti-rabbit-FITC, Santa Cruz Biotechnology Inc.,
Santa Cruz, Calif, USA; polyclonal rabbit anti-mouse-FITC,
Dako, Glostrup, Denmark) was also performed overnight
at 4◦C. DAPI staining and mounting were performed using
DAPI-containing Vectashield mounting medium (Vector
Laboratories, Burlingame, Calif, USA).
2.3. Alkaline Phosphatase Assay. Cells were ﬁxed in 4% for-
maldehyde for two minutes at room temperature and rinsed
with TBST (20mM Tris-HCl, pH 7.4, 0.15M NaCl, 0.05%
Tween-20). They were then incubated, according to the
manufacturer’s protocol, in a mixture of Fast Red Violet,
Naphthol AS-BI phosphate solution, and water from the
Alkaline Phosphatase Detection Kit (Millipore, Billerica,
Mass, USA). Before observation under the microscope, the
cells were rinsed with TBST and covered with PBS. To
estimate the alkaline phosphatase-positive (AP+) cell frac-
tion, cells in colonies from representative 40X-magniﬁcation
microscope ﬁelds were counted and evaluated as either AP+
or AP− based on staining intensity. The AP+ fraction was
calculated by dividing the AP+ cell number by the total
number of cells evaluated.
2.4. Microscopy. Immunoﬂuorescence was viewed using an
Imager. Z1 microscope (Zeiss, Gottingen, Germany). Live
cells, alkaline phosphatase-tested colonies, and histological
sections were viewed using an Observer. A1 microscope
(Zeiss). Images were acquired using AxioVision software.
2.5.Immunoblotting. Celllysateswerepreparedaspreviously
described [16]. 100μg of cell lysates from each cell strain
was separated by SDS-PAGE (10% polyacrylamide). Proteins
were blotted to a Hybond ECL membrane in Tris-glycine-
methanol buﬀer (25mM Tris-HCl, pH 7.5, 190mM glycine,
20% methanol) for 2 hours at 120 volts on ice. The
membrane was blocked with Tris-buﬀered saline (TBS)
containing 10% dried milk and 0.1% Tween-20 at room
temperature for one hour. Polyclonal rabbit anti-Pdx1 anti-
body (Millipore, Billerica, Mass, USA) was diluted 1:5000
in blocking solution and incubated overnight at 4◦Cw i t hJournal of Biomedicine and Biotechnology 3
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Figure 1: The SACK method for the expansion of tissue stem cells. (a) In vivo, tissue stem cells divide with asymmetric cell kinetics to
produce progeny that eventually undergo a terminal cell cycle arrest and diﬀerentiate. Asymmetric cell kinetics maintains an equilibrium
between renewal of diﬀerentiated tissue cells and preservation of constant tissue stem cell number. When tissue stem cells are cultured
ex vivo, asymmetric cell kinetics results in their dilution and loss as a consequence of the accumulation of their diﬀerentiating progeny
cells. The SACK method shifts tissue stem cells to symmetric cell kinetics that reversibly promotes their exponential expansion. Green
circles, tissue stem cells; yellow circles, transient-amplifying lineage-committed cells; red circles, terminally arrested diﬀerentiated cells. (b)
The guanine ribonucleotide biosynthesis pathway that controls tissue stem cells’ self-renewal pattern. The rate-limiting step for cellular
guanine ribonucleotide biosynthesis is the formation of xanthosine-5 -monophosphate (XMP) from inosine-5 -monophosphate (IMP), the
reaction catalyzed by inosine-5 -monophosphate dehydrogenase II (IMPDH II). The asymmetric cell kinetics of tissue stem cells requires
downregulation of IMPDH II expression by the tumor suppressor protein p53. Supplementation with exogenous guanine ribonucleotide
precursors, like xanthosine, which expands guanine ribonucleotide pools, converts tissue stem cells to symmetric cell kinetics despite
normal p53 expression. Cells expressing a xanthine phosphoribosyl transferase (XPRT) transgene can use the highly membrane-permeable
precursor xanthine to achieve symmetric cell kinetics. GMP, guanosine monophosphate; NsK, nucleoside kinase; PNP, purine nucleoside
phosphorylase; XO, xanthine oxidase.
the membrane. Following four 15-minute washes in TBST,
the membrane was incubated with ECL anti-rabbit-HRP
(GE Healthcare, Waukesha, Wis, USA) diluted at 1:2000 in
blocking solution. HRP-conjugated antibodies were detected
using Amersham ECL Plus Western Blotting Detection Sys-
tem (GE Healthcare), followed by auto-photography.
2.6. Tumor Formation Assays. mPanstra-12 and mPanstra-
25 cells, mESCs, and reprogrammed 12-KOSR-Xn-83, 12-
KOSR-Xn-89, 25-KOSR-Xn-85, and 25-KOSR-Xn-86 cells
were collected by trypsinization followed by three washes
with PBS. Viable cell number was determined using a Vi-
Cell XR Cell Viability Analyzer (Beckman Coulter, Brea,
Calif, USA). For each cell type, two immunodeﬁcient mice
(3-month-old nude-Foxn1nu females; Harlan Laboratories)
were injected subcutaneously in each hind limb (two injec-
tions per mouse, four injections per cell type) with 5 × 106
cellsusinga26Gneedle.Injectedmicewereevaluatedtwicea
weekfordevelopmentoftumors.Allanimalprocedureswere
approved by the BBRI Animal Care and Use Committee.
2.7. Histology. Tumors were dissected and ﬁxed overnight in
formalin. They were transferred to 70% ethanol and shipped
to Mass Histology Service (Worcester, Mass, USA) for proc-
essing, embedding, sectioning (5μm), and hematoxylin-
eosin staining.
3.Background to the Study
Asymmetric self-renewal is a unique feature of tissue stem
cells [19]. In adult tissues, tissue stem cells divide asym-
metrically, resulting in the production of a new tissue stem
cell and a lineage-committed progenitor, the latter having
a limited proliferative potential. While this mechanism
provides an equilibrium by maintaining a constant number
of tissue stem cells in tissues, it limits the ex vivo expan-
sion of tissue stem cells (Figure 1(a)). Asymmetric self-
renewal by tissue stem cells in vitro leads to their dilution
and eventual loss during serial passage. To overcome this
asymmetric cell kinetics barrier, we developed the SACK
method[20,21].SACKpromotestissuestemcells’expansion
by reversibly converting asymmetric self-renewal kinetics
to symmetric self-renewal kinetics. Symmetric cell kinetics
promotes exponential expansion of tissue stem cells to
the exclusion of production of lineage-committed progeny
cells. Asymmetric cell kinetics requires a p53-dependent
decrease in guanine ribonucleotide biosynthesis, speciﬁcally
resulting from the repression of inosine-5 -monophosphate
dehydrogenase II (IMPDH II) (Figure 1(b))[ 23–25]. The
SACK method uses speciﬁc exogenous guanine ribonu-
cleotide salvage precursors and/or genes that circumvent
the biochemical consequences of IMPDH II downregulation
by acting either upstream or downstream of the reaction4 Journal of Biomedicine and Biotechnology
catalyzed by IMPDH II, which is rate limiting for guanine
ribonucleotide biosynthesis.
In the presented study, we used SACK-expanded adult
mouse pancreatic stem cell strains derived from transgenic
mice expressing the xanthine phosphoribosyl transferase
(XPRT) gene [26] .T h eX P R Tg e n ei sa b s e n ti nm a m -
malians. It catalyzes the conversion of Xn to xanthosine-
5 -monophosphate (XMP), the product of the IMPDH
II reaction with its substrate inosine-5 -monophosphate
(IMP). Xn supplementation allowed expansion of pancreatic
stem cells strains from adult XPRT-transgenic mice by
promoting guanine ribonucleotide production downstream
of the p53-regulation point. Properties of these cells will
be reported in detail elsewhere. In brief, they were derived
from isolated islets; their proliferation is optimal under
Xn-supplementation conditions (i.e., more tissue stem cells
are produced), and they have pancreatic endocrine cell
diﬀerentiation potential. Although the cell strains are clonal,
their cultures are composed of a mixture of tissue stem cells,
lineage-committed pancreatic progenitor cells, and nonpro-
liferating cells. We refer to these SACK-expanded, clonal,
adult (i.e., eight-month old mice) mouse pancreatic stem
cells as “mPanstra” strains. Although all mPanstra strains
required Xn for their derivation, some are highly dependent
on Xn to achieve their maximum proliferative rate (i.e.,
Xn-dependent, SACK-D[ependent] strains), whereas others
maintain high rates of proliferation without Xn supplemen-
tation (i.e., Xn-independent, SACK-I[ndependent] strains).
SACK-I strains are tumorigenic, but SACK-D strains are not.
The SACK-D clones are nontumorigenic pancreatic stem cell
strains (manuscript in preparation).
Tissue stem cells share more gene expression networks
with pluripotent stem cells than do other somatic cells [27,
28]. We considered that these gene expression similarities,
in combination with SACK-induced symmetric self-renewal,
might predispose tissue stem cells for greater eﬃciency in
conversion to a pluripotent phenotype. Here, we report
evidence that adult mouse pancreatic stem cells derived
by the SACK method can be converted to increased tissue
potency without the use of exogenous transcription factors.
Based on the criterion of formation of teratomas with
tissues that originate from all three embryonic germ layers
(i.e., endoderm, mesoderm, and ectoderm), the cells attain
full pluripotency. We also show that the SACK agent Xn
signiﬁcantly increases the eﬃciency of SACK-D strains
to convert to increased tissue potency. We propose that
this ability reﬂects the common involvement of p53 gene
regulation in induced pluripotent stem cell production [29–
32] and tissue stem cell self-renewal kinetics [19, 20, 24, 25].
4. Results
4.1. Culture Conditions for Mouse Pluripotent Stem Cells
Alter the Growth Kinetics of mPanstra Tissue Stem Cell
Strains. Consistent with the concept of some shared gene
expression networks between pluripotent stem cells and
tissue stem cells, transcription factors used to induce for-
mation of pluripotent stem cells are detected in mPanstra
strains. Under Xn-supplementation conditions, two evalu-
ated SACK-D strains, mPanstra-12 and mPanstra-25, show
expression of nuclear Klf4 in a subset of cells (Figure 2(a)),
while Oct4 expression can only be detected in the mPanstra-
12 strain (Figure 2(b)). Although Klf4 detection was weaker,
it was speciﬁc. STO ﬁbroblast feeder cells in comparison
to mESC cultures were negative for Klf4 ﬂuorescence
(Figure 2(a)). No Sox2 expression was detected.
Given their basal expression of genes associated with
pluripotency, we investigated whether maintaining mPanstra
cells under culture conditions for pluripotent stem cells
would promote their conversion to a pluripotent state. Six
related culture conditions were evaluated (see Figure 3(a)).
All six conditions used gelatin-coated dishes covered with
a monolayer of STO ﬁbroblast feeder cells. In the ﬁrst
two conditions, evaluated mPanstra strains were cultured
in their own maintenance medium, which is supplemented
with dialyzed fetal bovine serum (DFBS), either without or
with Xn supplementation (DFBS-Ctrl and DFBS-Xn, resp.).
The third and fourth conditions employed culture medium
commonly used for the growth of mouse embryonic stem
cells (mESCs) that was supplemented with a high con-
centration of heat-inactivated, nondialyzed FBS and other
factors required for the maintenance of pluripotency. This
“hiFBS” condition was also evaluated either without or with
Xn supplementation (hiFBS-Ctrl and hiFBS-Xn, resp.). The
ﬁnal two conditions were based on a more recently available
deﬁned condition used to maintain and grow pluripotent
stem cells. Basically, heat-inactivated serum is substituted
with KnockOut Serum Replacement (“KOSR”). Again, this
medium was evaluated without or with Xn supplementation
(KOSR-Ctrl and KOSR-Xn, resp.).
The most prominent eﬀect noted upon transfer of the
mPanstra strains to the six trial reprogramming conditions
was a general inhibition of the cell proliferation of SACK-D
strains.Duringtheﬁrstweekofgrowth,mPanstracellsplated
in parallel at the same starting cell number in their routine
maintenance conditions attained conﬂuency. In contrast,
only the SACK-I strains (mPanstra-11 and mPanstra-56)
reached conﬂuency in all reprogramming conditions. The
SACK-D strains (mPanstra-12 and mPanstra-25) showed
reduced cell proliferation in the reprogramming conditions,
and even after two weeks, only cell colonies had formed.
4.2. Under Reprogramming Conditions, SACK-D mPanstra
Stem Cell Strains Acquire Phenotypic Properties of Pluripotent
Stem Cells. Two weeks after the transfer, two types of
colonies were observed for the SACK-D strains in the
reprogramming conditions: striated colonies and epithelial-
like colonies (Figure 3(b)). The latter morphology resembled
pluripotent stem cells. Some colonies developed subsets
of cells with alkaline phosphatase activity (red cells in
Figure 3(c)), a property of pluripotent stem cells [33].
For each SACK-D strain reprogramming condition,
we picked 24 well-isolated colonies for clonal expansion.
The proportion of striated versus epithelial colonies picked
reﬂected their initial reprogramming fractions. Following
expansion, each subclone was graded for morphology and
alkaline phosphatase activity (Figure 4). All the subclonesJournal of Biomedicine and Biotechnology 5
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Figure 2: Expression of pluripotency factors in SACK-D mPanstra cells. (a) Nuclear expression of Klf4 was evaluated by indirect in
situ immunoﬂuorescence (ISIF) with Klf4-speciﬁc antibodies. (b) Nuclear expression of Oct4 was evaluated by ISIF with Oct4-speciﬁc
antibodies. In each analysis, mouse embryonic stem cells (mESCs) were analyzed as a positive control. DAPI, nuclear DNA ﬂuorescence.6 Journal of Biomedicine and Biotechnology
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Figure 3: Derivation of reprogrammed colonies by culturing mPanstra cells under pluripotent stem cell culture conditions. (a) mPanstra
cells grown in their maintenance medium were transferred to monolayers of STO feeder cells in medium supplemented with dialyzed
fetal bovine serum (DFBS), heat-inactivated fetal bovine serum (hiFBS), or KnockOut Serum Replacement (KOSR). Each type of serum
supplement was evaluated with (Xn) or without (Ctrl) Xn supplementation. Only SACK-D strains mPanstra-12 and mPanstra-25 formed
colonies. (b) SACK-D mPanstra strains (top panel, under routine culture conditions) generate two types of colonies two weeks after transfer
intoreprogrammingconditions:striated(str,middlepanels)orepithelial-like(epl,lowerpanels).(c)Asubsetofcellsfromepithelialcolonies
express alkaline phosphatase (red color, indicated by arrows), a general pluripotency marker. Scale bars = 100μm.Journal of Biomedicine and Biotechnology 7
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Figure 4: Evaluation of the morphology and alkaline phosphatase activity of expanded reprogrammed colonies of SACK-D strains
mPanstra-12 and mPanstra-25. Shown are examples of phase micrographs of colonies developed from reprogrammed cell clones and
stained for alkaline phosphatase activity. The estimated alkaline-phosphatase-positive (AP+) cell fractions for colonies with epithelial
(epl) or striated (str) morphology were 100% for mESCs, 10% for 25-KOSR-Xn-92 (SACK-D strain #—derivation medium—xanthine
supplementation—subclone #), 50% for 12-DFBS-Xn-45, and 90% for 12-KOSR-Xn-89. Scale bars = 100μm.
originating from the mPanstra-25 strain and derived in
DFBS reprogramming conditions uniformly exhibited the
striated morphology, and none of them showed detectable
alkaline phosphatase activity (Table I(a)). There was a signif-
icant shift toward the epithelial morphology in the subclones
fromthehiFBSconditions,withlessthanathirdoftheclones
having the striated morphology. In the subclones showing
alkaline phosphatase activity, the proportion of positive cells
was estimated to vary from 5% to 50% (see example in
Figure 4, top right panel). More dramatic was the change in
the KOSR reprogramming conditions. Only the subclones
with the epithelial morphology could be expanded, and
the Xn-supplementation condition had more than twice
the proportion of subclones showing alkaline phosphatase
activity. Moreover, the proportion of alkaline phosphatase-
positive cells was estimated to range from 5% to 60% with
Xn supplementation, while never being higher than 20% in
its absence.
In the case of the mPanstra-12 subclones, about a
third of these that were derived in the DFBS reprogram-
ming conditions had the epithelial morphology. However,
none of these epithelial subclones had detectable alkaline
phosphatase activity, even though some of the striated
subclones showed activity (Table I(b)). In the hiFBS repro-
gramming conditions, there was no obvious shift from
striated to epithelial morphology, but three of the eight
epithelial subclones obtained showed alkaline phosphatase
activity under conditions for Xn supplementation. For the
KOSR reprogramming conditions, we observed a signiﬁcant
shift toward the epithelial morphology with Xn (15 out of
17 expanded clones; Table I(b)), with two-thirds of them
showing alkaline phosphatase activity. Overall, in KOSR
medium,Xnincreasedtherateofepithelialcolonyformation
by mPanstra-12 subclones 1.8-fold (P = 0.044; two-tailed
Fisher’s exact test).
The ﬁnding that colonies with an epithelial morphology
readily developed in DFBS reprogramming conditions only
from the mPanstra-12 strain suggested that mPanstra-12
might be a developmentally less committed stem cell strain
thanthemPanstra-25strain.Inearlierstudies,wehavefound
that the SACK method could expand distinct stem cell types
from the same tissue [21]. Consistent with this hypothesis,
mPanstra-12 cells do not express the early pancreatic marker
Pdx1 [34] at detectable protein levels (Figure 5), suggesting
that mPanstra-12 is less committed toward a speciﬁc dif-
ferentiation pathway (e.g., pancreatic). Thereby, it could be
more susceptible to conversion to increased tissue potency.
4.3. Reprogrammed Subclones of the SACK-D, Pdx1-Negative
mPanstra-12 Strain Produce Teratomas Indicative of Pluripo-
tency. To evaluate the developmental tissue potency of the
subclones with epithelial morphology, we assayed them for
their capacity to form teratomas following subcutaneous
injections into immunodeﬁcient mice. Mouse ESCs and
iPSCs are characterized by their ability to form teratomas,
that is, tumors that contain diﬀerentiated cells originating
from the three embryonic germ layers.
For each SACK-D strain, we selected two subclones
derived in the KOSR-Xn reprogramming conditions. For
both SACK-D mPanstra strains, this was the condition8 Journal of Biomedicine and Biotechnology
Table 1
(a) Phenotypes of individual reprogrammed subclones from the mPanstra-25 cell strain following expansion in respective reprogramming conditions.
Condition Phenotype
str, AP− str, AP+ epl, AP− epl, AP+
DFBS-Ctrl 23/23 (100%) 0/23 (0%) 0/23 (0%) 0/23 (0%)
0.06 0.00 0.00 0.00
DFBS-Xn 22/22 (100%) 0/22 (0%) 0/22 (0%) 0/22 (0%)
0.06 0.00 0.00 0.00
hiFBS-Ctrl 4/20 (20%) 1/20 (5%) 9/20 (45%) 6/20 (30%)
0.01 0.00 0.02 0.02
hiFBS-Xn 5/19 (26%) 1/19 (5%) 10/19 (53%) 3/19 (16%)
0.01 0.00 0.03 0.01
KOSR-Ctrl 0/16 (0%) 0/16 (0%) 14/16 (87.5%) 2/16 (12.5%)
0.00 0.00 0.04 0.01
KOSR-Xn 0/20 (0%) 0/20 (0%) 14/20 (70%) 6/20 (30%)
0.00 0.00 0.04 0.02
(b) Phenotypes of individual reprogrammed subclones from the mPanstra-12 cell strain following expansion in respective reprogramming conditions.
Condition Phenotype
str, AP− str, AP+ epl, AP− epl, AP+
DFBS-Ctrl 8/21 (38%) 5/21 (24%) 8/21 (38%) 0/21 (0%)
0.05 0.03 0.05 0.00
DFBS-Xn 12/23 (52%) 4/23 (17%) 7/23 (31%) 0/23 (0%)
0.08 0.03 0.05 0.00
hiFBS-Ctrl 18/24 (75%) 0/24 (0%) 6/24 (25%) 0/24 (0%)
0.12 0.00 0.04 0.00
hiFBS-Xn 11/19 (58%) 0/19 (0%) 5/19 (26%) 3/19 (16%)
0.07 0.00 0.03 0.02
KOSR-Ctrl 4/14 (29%) 3/14 (21%) 1/14 (7%) 6/14 (43%)
0.03 0.02 0.01 0.04
KOSR-Xn 1/17 (6%) 1/17 (6%) 5/17 (29%) 10/17 (59%)
0.01 0.01 0.03 0.07
AP−: alkaline phosphatase negative; AP+: alkaline phosphatase positive; epl: epithelial-like; str: striated
The number below each colony phenotype fraction corresponds to the estimated colony formation eﬃciency as a percentage of the number of cells used
to initiate reprogramming cultures (see Figure 3(a)).
leading to the highest fraction of subclones showing both
the epithelial morphology and alkaline phosphatase activity.
For each strain, one selected subclone had no detectable
alkalinephosphataseactivity(AP−;12-KOSR-Xn-83and25-
KOSR-Xn-86), whereas the other had the highest proportion
of alkaline phosphatase-positive cells (AP+; 12-KOSR-Xn-89
(see Figure 4) and 25-KOSR-Xn-85; 90% and 60%, resp.).
Two mice were injected subcutaneously in their hind
limbs with each of the four subclones, respectively (i.e., four
injection sites for each subclone). In parallel, two mice were
injected similarly with either mESCs or the parental SACK-
D mPanstra cell strains. Four weeks after the injections, the
mice receiving the mESCs showed tumors at all injection
sites. The mESC-derived tumors had histological features
of all three embryonic germ layers (Figure 6). Among the
other cells injected, only the subclones derived from the
mPanstra-12 strain formed small masses (at all injection
sites, both AP− and AP+) four months after injection. The
growth of these masses was slow, and two additional months
were allowed before euthanizing the mice and analyzing
the tumors (Figure 7), at which point the other injected
mice were also euthanized and their tumor-free status
conﬁrmed. Histological analysis of the tumors derived from
the reprogrammed mPanstra-12 cells (Figure 6) revealed the
presence of tissues of mesodermal (e.g., cartilage (ca) and
muscle (mu)), endodermal (e.g., digestive tract epithelium
(de)), and ectodermal (e.g., nerves (ne)) origin, conﬁrming
acquisition of pluripotency.
5. Discussion
5.1. Pluripotency Reprogramming by Targeting Tissue Stem
Cells. Ex vivo-expanded adult mouse pancreatic stem cell
strains were evaluated for their ability to acquire phenotypic
properties of pluripotent stem cells when transferred into
culture conditions permissive for the derivation and mainte-
nance of pluripotent stem cells. Because of the requirement
thattissuestemcellsmaintainanundiﬀerentiatedphenotypeJournal of Biomedicine and Biotechnology 9
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Figure 5: Pdx1 expression in SACK-D mPanstra pancreatic stem
cell strains. Immunoblot analyses were performed with whole cell
lysates (100μg protein each) from the indicated mPanstra stem cell
strains grown in their maintenance medium. The arrow indicates
the 45kDa Pdx1 protein detected with speciﬁc antibodies.
with respect to the tissue lineages that they replenish, we
considered that they might have gene expression networks
that were more susceptible to pluripotent reprogramming
by environmental factors found in pluripotent cell culture
media. Subsequently, we found that the SACK-D mPanstra
strains show expression of a subset of transcription fac-
tors (Oct4, Klf4) implicated in pluripotency state control
mechanisms. This ﬁnding advanced further the possibility
that these cells were, in fact, predisposed to pluripotency
reprogramming.
Supporting this tissue stem cell target hypothesis, both
of the evaluated SACK-D mPanstra stem cell strains showed
evidence of reprogramming after exposure to pluripotent
cell culture conditions. However, only strain mPanstra-12
achieved properties indicative of complete pluripotency con-
version. Since the parental SACK-D strains were clonal, did
notformtumorsthemselves,andwereofendodermalorigin,
pluripotency was acquired after the transfer into reprogram-
mingmedia.Theparticulardiﬀerencesnotedbetweenrepro-
grammed mPanstra-12 cells and reprogrammed mPanstra-
25 cells may account for their diﬀerence in teratoma forma-
tion. The mPanstra-12 cells showed expression of two plu-
ripotency factors (Klf4 and Oct4) in some cells, whereas only
Klf4 was detected in mPanstra-25 cells. Also, when com-
pared with mPanstra-25 cells, expression of the pancreatic
determination factor Pdx1 was not detected in mPanstra-
12 cells. These properties suggest that the mPanstra-12 cells
were already less committed to the pancreatic diﬀerentiation
pathway and that the gene expression networks necessary for
reprogramming were more active, which could explain their
increased potency.
Recent studies suggest that partial reprogramming of
ﬁbroblasts may provide attractive alternatives for producing
cells that can replenish speciﬁc tissues [35, 36]. Such strate-
gies highlight the well-recognized, but often understated,
ﬂaw in proposed pluripotency-based cell therapies, teratoma
formation. The possibility of altering the tissue potency of
tissue stem cells simply by transferring them into a deﬁned
culture environment underlies another approach to avoiding
the inherent risks of pluripotency. In the future, culture
environment might be used to instruct plentiful tissue stem
cells (e.g., SACK-expanded) to switch their potency to a
single tissue type of greater clinical need.
5.2. The Role of Guanine Ribonucleotide Precursors in Pluripo-
tency Reprogramming. KOSR-supplemented medium was
the most stringent reprogramming condition used. The
presence of Xn in this reprogramming condition increased
the frequency of subclones showing epithelial morphology
and alkaline phosphatase activity. Xn is known to act on
the parental stem cell strains by increasing the rate of sym-
metric self-renewal over asymmetric self-renewal, their
default pattern [20]. Making the target cells adopt a sym-
metric self-renewal cell division pattern could advance them
closer to a pluripotent stem cell phenotype, characterized by
symmetric self-renewal (in the cases of mESCs and iPSCs).
However, clearly more is at play than just acquisition of a
symmetric self-renewal state. SACK-I strains which undergo
constitutive symmetric self-renewal were unable to produce
reprogrammed cells. The molecular mechanisms responsible
fortheemergenceofSACK-Istrainsarenotfullyunderstood,
but it seems most likely that they are pancreatic stem cells
that acquired transforming cell mutations, prior to or after
their culture. Because no stably propagated adult pancreatic
cell strains emerged in the absence of XPRT transgenesis
and Xn supplementation, it seems likely that the proposed
mutations occur during or after SACK expansion. Although
transformed clones like the SACK-I strains develop, the
SACK method greatly limits their frequency, so that SACK-D
stem cell strains can be obtained with a high eﬃciency.
Previousstudieshaveestablishedthatsupplementedpur-
ines like Xn regulate the self-renewing pattern of tissue-
speciﬁc stem cells by increasing guanine ribonucleotide bio-
synthesis[21].Theupstreamstepinthispathwayiscatalyzed
by IMPDH II, whose expression is controlled by the p53
tumor suppressor protein. Xn acts downstream of IMPDH
II regulation by p53 and, thereby, overcomes the action of
p53 on guanine ribonucleotide biosynthesis without altering
the action of p53 on other vital cellular functions. Recently,
several studies have demonstrated that loss of p53 function
was a major factor responsible for more eﬃcient derivation
of iPSCs [29–32]. A large part of the eﬀect of p53 loss on
iPSC eﬃciency may be the increased symmetric self-renewal
by tissue stem cells in treated cell preparations as a result of
increased guanine ribonucleotide biosynthesis.
As noted earlier, among the many challenges to using
iPSC-derived cells in transplantation medicine, carcinogenic
transformation, beyond the gnomonic teratoma formation
of pluripotent stem cells injected into mature tissues, is a
major one. Thus, the recent major goal in iPSC research has
been achieving complete reprogramming at high eﬃciency
without resorting to gene transduction approaches. Many
studies have shown that gene transduction by a variety of
strategies can result in insertional mutagenesis that can10 Journal of Biomedicine and Biotechnology
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Figure 6: Reprogrammed cell clones derived from SACK-D pancreatic stem cell strain mPanstra-12 form teratomas in immunodeﬁcient
mice. Shown are micrographs of hematoxylin-and-eosin-stained tissue sections from subcutaneous tumors formed from mESCs or
reprogrammed12-KOSR-Xn-89(AP+)and12-KOSR-Xn-83(AP−)cellclones.Thecorrespondingembryonicgermlayerofeachhistological
example is indicated. ca, cartilage; mu, muscle; de, digestive tract epithelium; nc, neurectoderm; ne, nerve. Scale bars = 50μm.
Figure 7: Example of a subcutaneous tumor derived from the
12-KOSR-Xn-89 reprogrammed cells. The photographed tumor
(bottom right corner) was excised six months after subcutaneous
injection of 5 ×106 cells. A recipient mouse is shown for scale.
lead to cellular transformation and neoplasia [3, 37]. Gene
transduction was recently circumvented by transducing cells
directly with mRNAs encoding reprogramming proteins or
reprogramming proteins themselves [9–11]. Also, transduc-
tion with only one pluripotency factor in combination with
cell culture supplementation with speciﬁc small molecules
has led to successful reprogramming [12–14]. Adding Xn
and/or other exogenous guanine ribonucleotide precursors
(e.g., xanthosine, hypoxanthine [38]) to the reprogramming
environmentcouldprovideanimportantelementtoincrease
iPSC production eﬃciency. Moreover, the use of starting cell
populations containing tissue-speciﬁc stem cells undergoing
symmetric self-renewal could provide even more eﬃcient
production of iPSCs.
Even with gene-free reprogramming, the long assumed
inherent cellular transformation risk of pluripotency would
still be present. Previously, this risk had been attributed to
poor regulation of pluripotent cells by heterologous tissue
environments [39, 40]. However, this view may change
soon, because, recently, both human ESCs and human
iPSCs were discovered to contain many mutations in well-
known oncogenes and tumor-suppressor genes, indicating
that their production is inherently carcinogenic [41, 42]. The
reprogramming process of iPSCs is associated with deletions
of tumor suppressor genes, followed by duplications of
oncogenes during expansion in culture [42]. The slow tumor
development that we observe after culture environment
reprogramming of pancreatic tissue stem cells could lead
to a safer alternative. Speciﬁc tissue stem cell types could
p r o v em o r es e n s i t i v ef o rt i s s u ep o t e n c yr e p r o g r a m m i n g
and/or less prone to cellular transformation. Of course,
recognizing such success will require assays that do not
require tumor formation for evaluation. Looking for the
ability of reprogrammed cells to replace injured tissues
or expand normal tissues of a diﬀerent embryonic germ
layer than their origin is the ideal assay concept. Also,Journal of Biomedicine and Biotechnology 11
the development of better-deﬁned culture conditions for
directing reprogramming could increase the eﬃciency and
decrease the time necessary for reprogramming.
6. Conclusion
We demonstrated that SACK-derived adult pancreatic tissue
stem cells could acquire properties of pluripotent stem cells
simply by culture under conditions used for production and
routine maintenance of the latter. Strain mPanstra-12, the
least developmentally committed SACK-D stem cell strain,
showed the greatest potency. It was the only one of the two
evaluated SACK-D strains that achieved teratoma formation.
Xn supplementation signiﬁcantly increased the eﬃciency
and degree of potency. The combination of pancreatic
tissue stem cells and Xn induction of symmetric self-
renewal may reﬂect the same cellular eﬀect as the loss of
p53 function for increasing reprogramming eﬃciency. We
predict that starting the reprogramming process with tissue
stem-cell-enriched populations, and Xn supplementation
(or other exogenous guanine ribonucleotide precursors)
will independently and synergistically enhance pluripotent
reprogramming into bona ﬁde induced pluripotent stem
cells while reducing the rate of emergence of clones with
transforming cell mutations.
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